nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluocinonide—Application site burn—Fluorouracil—pancreatic cancer	0.0214	0.0542	CcSEcCtD
Fluocinonide—SMO—Signaling events mediated by the Hedgehog family—PTCH1—pancreatic cancer	0.02	0.0331	CbGpPWpGaD
Fluocinonide—Dermatitis acneiform—Erlotinib—pancreatic cancer	0.0193	0.0487	CcSEcCtD
Fluocinonide—Telangiectasia—Fluorouracil—pancreatic cancer	0.0191	0.0482	CcSEcCtD
Fluocinonide—SMO—Hedgehog signaling events mediated by Gli proteins—GLI1—pancreatic cancer	0.0162	0.0268	CbGpPWpGaD
Fluocinonide—Leukoderma—Sunitinib—pancreatic cancer	0.0134	0.0339	CcSEcCtD
Fluocinonide—SMO—Hair Follicle Development: Induction (Part 1 of 3)—SHH—pancreatic cancer	0.0131	0.0216	CbGpPWpGaD
Fluocinonide—Allergic contact dermatitis—Fluorouracil—pancreatic cancer	0.0129	0.0325	CcSEcCtD
Fluocinonide—SMO—Hair Follicle Development: Induction (Part 1 of 3)—PTCH1—pancreatic cancer	0.0124	0.0205	CbGpPWpGaD
Fluocinonide—SMO—Hedgehog signaling events mediated by Gli proteins—SHH—pancreatic cancer	0.0117	0.0194	CbGpPWpGaD
Fluocinonide—SMO—Hedgehog signaling events mediated by Gli proteins—PTCH1—pancreatic cancer	0.0111	0.0184	CbGpPWpGaD
Fluocinonide—SMO—GPCRs, Other—SSTR2—pancreatic cancer	0.0107	0.0177	CbGpPWpGaD
Fluocinonide—Folliculitis—Erlotinib—pancreatic cancer	0.0105	0.0265	CcSEcCtD
Fluocinonide—SMO—GPCRs, Other—CCKBR—pancreatic cancer	0.0103	0.0171	CbGpPWpGaD
Fluocinonide—Application site pain—Fluorouracil—pancreatic cancer	0.0102	0.0258	CcSEcCtD
Fluocinonide—Application site reaction—Fluorouracil—pancreatic cancer	0.00958	0.0242	CcSEcCtD
Fluocinonide—SMO—Hedgehog 'off' state—GLI1—pancreatic cancer	0.00917	0.0152	CbGpPWpGaD
Fluocinonide—SMO—Class B/2 (Secretin family receptors)—SCT—pancreatic cancer	0.00875	0.0145	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—TFF1—pancreatic cancer	0.00847	0.014	CbGpPWpGaD
Fluocinonide—SMO—Signaling by Hedgehog—GLI1—pancreatic cancer	0.00818	0.0135	CbGpPWpGaD
Fluocinonide—SMO—Class B/2 (Secretin family receptors)—GLP1R—pancreatic cancer	0.00813	0.0134	CbGpPWpGaD
Fluocinonide—Secondary infection—Epirubicin—pancreatic cancer	0.00744	0.0188	CcSEcCtD
Fluocinonide—Eruption—Gemcitabine—pancreatic cancer	0.00743	0.0188	CcSEcCtD
Fluocinonide—SMO—Class B/2 (Secretin family receptors)—SHH—pancreatic cancer	0.00729	0.0121	CbGpPWpGaD
Fluocinonide—SMO—Class B/2 (Secretin family receptors)—IAPP—pancreatic cancer	0.0072	0.0119	CbGpPWpGaD
Fluocinonide—SMO—Class B/2 (Secretin family receptors)—PTCH1—pancreatic cancer	0.00691	0.0114	CbGpPWpGaD
Fluocinonide—SMO—Class B/2 (Secretin family receptors)—PTHLH—pancreatic cancer	0.00691	0.0114	CbGpPWpGaD
Fluocinonide—Secondary infection—Doxorubicin—pancreatic cancer	0.00689	0.0174	CcSEcCtD
Fluocinonide—NR3C1—Nuclear Receptors—NR5A2—pancreatic cancer	0.00652	0.0108	CbGpPWpGaD
Fluocinonide—Skin exfoliation—Tamoxifen—pancreatic cancer	0.00635	0.0161	CcSEcCtD
Fluocinonide—SMO—Hedgehog 'off' state—PTCH1—pancreatic cancer	0.00629	0.0104	CbGpPWpGaD
Fluocinonide—Skin exfoliation—Erlotinib—pancreatic cancer	0.00628	0.0159	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—DAXX—pancreatic cancer	0.00615	0.0102	CbGpPWpGaD
Fluocinonide—SMO—Hair Follicle Development: Induction (Part 1 of 3)—EGF—pancreatic cancer	0.00592	0.00979	CbGpPWpGaD
Fluocinonide—SMO—Signaling by Hedgehog—SHH—pancreatic cancer	0.00592	0.00979	CbGpPWpGaD
Fluocinonide—SMO—Class B/2 (Secretin family receptors)—GCG—pancreatic cancer	0.00564	0.00932	CbGpPWpGaD
Fluocinonide—SMO—GPCRs, Other—CNR1—pancreatic cancer	0.00563	0.00931	CbGpPWpGaD
Fluocinonide—SMO—Signaling by Hedgehog—PTCH1—pancreatic cancer	0.00561	0.00928	CbGpPWpGaD
Fluocinonide—Swelling—Tamoxifen—pancreatic cancer	0.00547	0.0138	CcSEcCtD
Fluocinonide—Skin exfoliation—Sunitinib—pancreatic cancer	0.00544	0.0137	CcSEcCtD
Fluocinonide—Eruption—Docetaxel—pancreatic cancer	0.00527	0.0133	CcSEcCtD
Fluocinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—PDX1—pancreatic cancer	0.00525	0.00868	CbGpPWpGaD
Fluocinonide—NR3C1—Nuclear Receptor transcription pathway—NR5A2—pancreatic cancer	0.00516	0.00853	CbGpPWpGaD
Fluocinonide—Leukoderma—Epirubicin—pancreatic cancer	0.00514	0.013	CcSEcCtD
Fluocinonide—Leukoderma—Doxorubicin—pancreatic cancer	0.00476	0.012	CcSEcCtD
Fluocinonide—Nasal congestion—Sunitinib—pancreatic cancer	0.00454	0.0115	CcSEcCtD
Fluocinonide—SMO—Signaling events mediated by the Hedgehog family—PIK3CA—pancreatic cancer	0.00453	0.00749	CbGpPWpGaD
Fluocinonide—Dermatitis contact—Fluorouracil—pancreatic cancer	0.00444	0.0112	CcSEcCtD
Fluocinonide—Dry skin—Erlotinib—pancreatic cancer	0.00438	0.0111	CcSEcCtD
Fluocinonide—Skin exfoliation—Gemcitabine—pancreatic cancer	0.00436	0.011	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—WT1—pancreatic cancer	0.00433	0.00717	CbGpPWpGaD
Fluocinonide—SMO—Hair Follicle Development: Induction (Part 1 of 3)—CTNNB1—pancreatic cancer	0.00407	0.00673	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—SHH—pancreatic cancer	0.00389	0.00643	CbGpPWpGaD
Fluocinonide—NR3C1—Endoderm Differentiation—DAB2—pancreatic cancer	0.00388	0.00642	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—PRLHR—pancreatic cancer	0.00387	0.0064	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—IAPP—pancreatic cancer	0.00384	0.00635	CbGpPWpGaD
Fluocinonide—Dry skin—Sunitinib—pancreatic cancer	0.00379	0.00958	CcSEcCtD
Fluocinonide—SMO—Signaling events mediated by the Hedgehog family—AKT1—pancreatic cancer	0.0037	0.00612	CbGpPWpGaD
Fluocinonide—Swelling—Fluorouracil—pancreatic cancer	0.0037	0.00935	CcSEcCtD
Fluocinonide—Nasopharyngitis—Sunitinib—pancreatic cancer	0.0037	0.00935	CcSEcCtD
Fluocinonide—Eruption—Epirubicin—pancreatic cancer	0.00356	0.00899	CcSEcCtD
Fluocinonide—Folliculitis—Epirubicin—pancreatic cancer	0.00348	0.0088	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—EZH2—pancreatic cancer	0.00336	0.00555	CbGpPWpGaD
Fluocinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—SLC2A2—pancreatic cancer	0.00331	0.00547	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—GADD45A—pancreatic cancer	0.0033	0.00546	CbGpPWpGaD
Fluocinonide—SMO—Hair Follicle Development: Induction (Part 1 of 3)—MYC—pancreatic cancer	0.0033	0.00545	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—SSTR3—pancreatic cancer	0.00329	0.00544	CbGpPWpGaD
Fluocinonide—Eruption—Doxorubicin—pancreatic cancer	0.00329	0.00832	CcSEcCtD
Fluocinonide—SMO—Hair Follicle Development: Induction (Part 1 of 3)—EGFR—pancreatic cancer	0.00322	0.00533	CbGpPWpGaD
Fluocinonide—Hyperglycaemia—Sunitinib—pancreatic cancer	0.00322	0.00815	CcSEcCtD
Fluocinonide—Folliculitis—Doxorubicin—pancreatic cancer	0.00322	0.00814	CcSEcCtD
Fluocinonide—SMO—GPCR ligand binding—SSTR1—pancreatic cancer	0.00316	0.00522	CbGpPWpGaD
Fluocinonide—Skin exfoliation—Docetaxel—pancreatic cancer	0.0031	0.00783	CcSEcCtD
Fluocinonide—SMO—GPCR ligand binding—PPY—pancreatic cancer	0.00309	0.00512	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—SSTR2—pancreatic cancer	0.00304	0.00502	CbGpPWpGaD
Fluocinonide—Dry skin—Fluorouracil—pancreatic cancer	0.00299	0.00756	CcSEcCtD
Fluocinonide—SMO—GPCR ligand binding—CCKBR—pancreatic cancer	0.00293	0.00485	CbGpPWpGaD
Fluocinonide—Nasopharyngitis—Fluorouracil—pancreatic cancer	0.00292	0.00738	CcSEcCtD
Fluocinonide—Erythema—Tamoxifen—pancreatic cancer	0.00291	0.00735	CcSEcCtD
Fluocinonide—Erythema—Erlotinib—pancreatic cancer	0.00288	0.00727	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	0.00282	0.00467	CbGpPWpGaD
Fluocinonide—Glycosuria—Epirubicin—pancreatic cancer	0.0027	0.00683	CcSEcCtD
Fluocinonide—Swelling—Docetaxel—pancreatic cancer	0.00267	0.00675	CcSEcCtD
Fluocinonide—Hyperglycaemia—Gemcitabine—pancreatic cancer	0.00259	0.00654	CcSEcCtD
Fluocinonide—Immune system disorder—Sunitinib—pancreatic cancer	0.00258	0.00653	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	0.00255	0.00423	CbGpPWpGaD
Fluocinonide—Glycosuria—Doxorubicin—pancreatic cancer	0.0025	0.00632	CcSEcCtD
Fluocinonide—Erythema—Sunitinib—pancreatic cancer	0.00249	0.0063	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	0.00247	0.00409	CbGpPWpGaD
Fluocinonide—NR3C1—Transcription factor regulation in adipogenesis—PPARG—pancreatic cancer	0.00245	0.00405	CbGpPWpGaD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Erlotinib—pancreatic cancer	0.00243	0.00615	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	0.00243	0.00402	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—SCT—pancreatic cancer	0.00239	0.00396	CbGpPWpGaD
Fluocinonide—Infection—Tamoxifen—pancreatic cancer	0.00236	0.00596	CcSEcCtD
Fluocinonide—Infection—Erlotinib—pancreatic cancer	0.00233	0.0059	CcSEcCtD
Fluocinonide—Nervous system disorder—Erlotinib—pancreatic cancer	0.0023	0.00582	CcSEcCtD
Fluocinonide—SMO—GPCR ligand binding—CCK—pancreatic cancer	0.00228	0.00377	CbGpPWpGaD
Fluocinonide—Skin disorder—Erlotinib—pancreatic cancer	0.00228	0.00577	CcSEcCtD
Fluocinonide—SMO—GPCR ligand binding—CNR2—pancreatic cancer	0.00222	0.00368	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—GLP1R—pancreatic cancer	0.00222	0.00368	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—CCKAR—pancreatic cancer	0.00219	0.00362	CbGpPWpGaD
Fluocinonide—Dermatitis contact—Epirubicin—pancreatic cancer	0.00216	0.00547	CcSEcCtD
Fluocinonide—Dry skin—Docetaxel—pancreatic cancer	0.00216	0.00546	CcSEcCtD
Fluocinonide—Immune system disorder—Irinotecan—pancreatic cancer	0.00213	0.00538	CcSEcCtD
Fluocinonide—NR3C1—Endoderm Differentiation—PTHLH—pancreatic cancer	0.00213	0.00352	CbGpPWpGaD
Fluocinonide—Nasopharyngitis—Docetaxel—pancreatic cancer	0.0021	0.00532	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—pancreatic cancer	0.0021	0.00532	CcSEcCtD
Fluocinonide—Skin exfoliation—Epirubicin—pancreatic cancer	0.00209	0.00528	CcSEcCtD
Fluocinonide—Immune system disorder—Gemcitabine—pancreatic cancer	0.00207	0.00524	CcSEcCtD
Fluocinonide—SMO—Hedgehog signaling events mediated by Gli proteins—AKT1—pancreatic cancer	0.00205	0.0034	CbGpPWpGaD
Fluocinonide—Pain—Tamoxifen—pancreatic cancer	0.00203	0.00513	CcSEcCtD
Fluocinonide—Infection—Sunitinib—pancreatic cancer	0.00202	0.0051	CcSEcCtD
Fluocinonide—Pain—Erlotinib—pancreatic cancer	0.00201	0.00508	CcSEcCtD
Fluocinonide—Dermatitis contact—Doxorubicin—pancreatic cancer	0.002	0.00506	CcSEcCtD
Fluocinonide—Erythema—Gemcitabine—pancreatic cancer	0.002	0.00505	CcSEcCtD
Fluocinonide—SMO—GPCR ligand binding—SHH—pancreatic cancer	0.00199	0.0033	CbGpPWpGaD
Fluocinonide—Nervous system disorder—Sunitinib—pancreatic cancer	0.00199	0.00504	CcSEcCtD
Fluocinonide—SMO—Signaling by GPCR—PRLHR—pancreatic cancer	0.00199	0.00329	CbGpPWpGaD
Fluocinonide—Skin disorder—Sunitinib—pancreatic cancer	0.00197	0.00499	CcSEcCtD
Fluocinonide—SMO—GPCR ligand binding—IAPP—pancreatic cancer	0.00197	0.00326	CbGpPWpGaD
Fluocinonide—Erythema—Fluorouracil—pancreatic cancer	0.00196	0.00497	CcSEcCtD
Fluocinonide—NR3C1—Endoderm Differentiation—EZH2—pancreatic cancer	0.00194	0.0032	CbGpPWpGaD
Fluocinonide—Skin exfoliation—Doxorubicin—pancreatic cancer	0.00193	0.00489	CcSEcCtD
Fluocinonide—SMO—GPCR ligand binding—PTHLH—pancreatic cancer	0.00189	0.00313	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—PTCH1—pancreatic cancer	0.00189	0.00313	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	0.00184	0.00305	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—SSTR1—pancreatic cancer	0.00183	0.00302	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—GDI1—pancreatic cancer	0.00182	0.00301	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—GDI2—pancreatic cancer	0.00182	0.00301	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	0.00176	0.00292	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—SSTR2—pancreatic cancer	0.00176	0.00291	CbGpPWpGaD
Fluocinonide—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00175	0.00442	CcSEcCtD
Fluocinonide—Pain—Sunitinib—pancreatic cancer	0.00174	0.00439	CcSEcCtD
Fluocinonide—SMO—GPCR ligand binding—SST—pancreatic cancer	0.00173	0.00286	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—SSTR3—pancreatic cancer	0.00169	0.00279	CbGpPWpGaD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.00169	0.00427	CcSEcCtD
Fluocinonide—Pruritus—Tamoxifen—pancreatic cancer	0.00168	0.00424	CcSEcCtD
Fluocinonide—Infection—Irinotecan—pancreatic cancer	0.00166	0.0042	CcSEcCtD
Fluocinonide—Pruritus—Erlotinib—pancreatic cancer	0.00166	0.0042	CcSEcCtD
Fluocinonide—Nervous system disorder—Irinotecan—pancreatic cancer	0.00164	0.00415	CcSEcCtD
Fluocinonide—Infection—Gemcitabine—pancreatic cancer	0.00162	0.0041	CcSEcCtD
Fluocinonide—SMO—Signaling by GPCR—SSTR1—pancreatic cancer	0.00162	0.00268	CbGpPWpGaD
Fluocinonide—Nervous system disorder—Gemcitabine—pancreatic cancer	0.0016	0.00404	CcSEcCtD
Fluocinonide—SMO—GPCR ligand binding—CNR1—pancreatic cancer	0.0016	0.00264	CbGpPWpGaD
Fluocinonide—Infection—Fluorouracil—pancreatic cancer	0.00159	0.00403	CcSEcCtD
Fluocinonide—SMO—Signaling by GPCR—PPY—pancreatic cancer	0.00159	0.00263	CbGpPWpGaD
Fluocinonide—Skin disorder—Gemcitabine—pancreatic cancer	0.00158	0.004	CcSEcCtD
Fluocinonide—NR3C1—Nuclear Receptors—PPARG—pancreatic cancer	0.00158	0.00262	CbGpPWpGaD
Fluocinonide—Nervous system disorder—Fluorouracil—pancreatic cancer	0.00157	0.00398	CcSEcCtD
Fluocinonide—Dizziness—Tamoxifen—pancreatic cancer	0.00157	0.00397	CcSEcCtD
Fluocinonide—SMO—Signaling by GPCR—SSTR2—pancreatic cancer	0.00156	0.00258	CbGpPWpGaD
Fluocinonide—Dizziness—Erlotinib—pancreatic cancer	0.00155	0.00393	CcSEcCtD
Fluocinonide—SMO—GPCR ligand binding—GCG—pancreatic cancer	0.00154	0.00255	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—AHR—pancreatic cancer	0.00153	0.00253	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CCKBR—pancreatic cancer	0.00151	0.00249	CbGpPWpGaD
Fluocinonide—Hypersensitivity—Sunitinib—pancreatic cancer	0.0015	0.00379	CcSEcCtD
Fluocinonide—Rash—Tamoxifen—pancreatic cancer	0.0015	0.00378	CcSEcCtD
Fluocinonide—Dermatitis—Tamoxifen—pancreatic cancer	0.00149	0.00378	CcSEcCtD
Fluocinonide—Headache—Tamoxifen—pancreatic cancer	0.00149	0.00376	CcSEcCtD
Fluocinonide—Rash—Erlotinib—pancreatic cancer	0.00148	0.00374	CcSEcCtD
Fluocinonide—Dermatitis—Erlotinib—pancreatic cancer	0.00148	0.00374	CcSEcCtD
Fluocinonide—Immune system disorder—Docetaxel—pancreatic cancer	0.00147	0.00372	CcSEcCtD
Fluocinonide—Headache—Erlotinib—pancreatic cancer	0.00147	0.00372	CcSEcCtD
Fluocinonide—SMO—GPCR ligand binding—AGTR1—pancreatic cancer	0.00147	0.00243	CbGpPWpGaD
Fluocinonide—Dry skin—Epirubicin—pancreatic cancer	0.00146	0.00368	CcSEcCtD
Fluocinonide—Pruritus—Sunitinib—pancreatic cancer	0.00144	0.00364	CcSEcCtD
Fluocinonide—Pain—Irinotecan—pancreatic cancer	0.00143	0.00362	CcSEcCtD
Fluocinonide—NR3C1—Endoderm Differentiation—SMAD4—pancreatic cancer	0.00143	0.00236	CbGpPWpGaD
Fluocinonide—Nasopharyngitis—Epirubicin—pancreatic cancer	0.00142	0.00359	CcSEcCtD
Fluocinonide—Erythema—Docetaxel—pancreatic cancer	0.00142	0.00358	CcSEcCtD
Fluocinonide—Pain—Gemcitabine—pancreatic cancer	0.00139	0.00353	CcSEcCtD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—FOXM1—pancreatic cancer	0.00139	0.00229	CbGpPWpGaD
Fluocinonide—NR3C1—Circadian Clock—HIF1A—pancreatic cancer	0.00138	0.00229	CbGpPWpGaD
Fluocinonide—Pain—Fluorouracil—pancreatic cancer	0.00137	0.00347	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	0.00135	0.00224	CbGpPWpGaD
Fluocinonide—Dry skin—Doxorubicin—pancreatic cancer	0.00135	0.00341	CcSEcCtD
Fluocinonide—Dizziness—Sunitinib—pancreatic cancer	0.00134	0.0034	CcSEcCtD
Fluocinonide—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.00131	0.00332	CcSEcCtD
Fluocinonide—NR3C1—Transcription factor regulation in adipogenesis—TNF—pancreatic cancer	0.0013	0.00215	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—GAST—pancreatic cancer	0.00129	0.00214	CbGpPWpGaD
Fluocinonide—Rash—Sunitinib—pancreatic cancer	0.00128	0.00324	CcSEcCtD
Fluocinonide—Dermatitis—Sunitinib—pancreatic cancer	0.00128	0.00324	CcSEcCtD
Fluocinonide—Headache—Sunitinib—pancreatic cancer	0.00127	0.00322	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	0.00126	0.00208	CbGpPWpGaD
Fluocinonide—NR3C1—Nuclear Receptor transcription pathway—PPARG—pancreatic cancer	0.00125	0.00207	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—SMAD4—pancreatic cancer	0.00124	0.00205	CbGpPWpGaD
Fluocinonide—Hyperglycaemia—Epirubicin—pancreatic cancer	0.00124	0.00313	CcSEcCtD
Fluocinonide—Hypersensitivity—Irinotecan—pancreatic cancer	0.00123	0.00312	CcSEcCtD
Fluocinonide—SMO—Signaling by GPCR—SCT—pancreatic cancer	0.00123	0.00203	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	0.00122	0.00202	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	0.00121	0.002	CbGpPWpGaD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.0012	0.00303	CcSEcCtD
Fluocinonide—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00118	0.00299	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	0.00118	0.00195	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PRLHR—pancreatic cancer	0.00117	0.00194	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CCK—pancreatic cancer	0.00117	0.00194	CbGpPWpGaD
Fluocinonide—Pruritus—Gemcitabine—pancreatic cancer	0.00115	0.00292	CcSEcCtD
Fluocinonide—Infection—Docetaxel—pancreatic cancer	0.00115	0.00291	CcSEcCtD
Fluocinonide—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.00115	0.0029	CcSEcCtD
Fluocinonide—NR3C1—AP-1 transcription factor network—HIF1A—pancreatic cancer	0.00114	0.00189	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CNR2—pancreatic cancer	0.00114	0.00189	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—GLP1R—pancreatic cancer	0.00114	0.00189	CbGpPWpGaD
Fluocinonide—Nervous system disorder—Docetaxel—pancreatic cancer	0.00113	0.00287	CcSEcCtD
Fluocinonide—Pruritus—Fluorouracil—pancreatic cancer	0.00113	0.00287	CcSEcCtD
Fluocinonide—NR3C1—Adipogenesis—GADD45A—pancreatic cancer	0.00113	0.00188	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—PLAU—pancreatic cancer	0.00113	0.00187	CbGpPWpGaD
Fluocinonide—Skin disorder—Docetaxel—pancreatic cancer	0.00112	0.00284	CcSEcCtD
Fluocinonide—SMO—Signaling by GPCR—CCKAR—pancreatic cancer	0.00112	0.00186	CbGpPWpGaD
Fluocinonide—Dizziness—Irinotecan—pancreatic cancer	0.00111	0.0028	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—ZNRF3—pancreatic cancer	0.0011	0.00182	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—ACVR1B—pancreatic cancer	0.0011	0.00182	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	0.0011	0.00181	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	0.00107	0.00176	CbGpPWpGaD
Fluocinonide—Dizziness—Fluorouracil—pancreatic cancer	0.00106	0.00268	CcSEcCtD
Fluocinonide—Rash—Irinotecan—pancreatic cancer	0.00106	0.00267	CcSEcCtD
Fluocinonide—Dermatitis—Irinotecan—pancreatic cancer	0.00105	0.00267	CcSEcCtD
Fluocinonide—NR3C1—Endoderm Differentiation—NOTCH1—pancreatic cancer	0.00105	0.00174	CbGpPWpGaD
Fluocinonide—Headache—Irinotecan—pancreatic cancer	0.00105	0.00265	CcSEcCtD
Fluocinonide—Rash—Gemcitabine—pancreatic cancer	0.00103	0.0026	CcSEcCtD
Fluocinonide—Dermatitis—Gemcitabine—pancreatic cancer	0.00103	0.0026	CcSEcCtD
Fluocinonide—SMO—Signaling by GPCR—SHH—pancreatic cancer	0.00102	0.00169	CbGpPWpGaD
Fluocinonide—Headache—Gemcitabine—pancreatic cancer	0.00102	0.00258	CcSEcCtD
Fluocinonide—SMO—Signaling by GPCR—IAPP—pancreatic cancer	0.00101	0.00167	CbGpPWpGaD
Fluocinonide—Rash—Fluorouracil—pancreatic cancer	0.00101	0.00256	CcSEcCtD
Fluocinonide—Dermatitis—Fluorouracil—pancreatic cancer	0.00101	0.00255	CcSEcCtD
Fluocinonide—Headache—Fluorouracil—pancreatic cancer	0.001	0.00254	CcSEcCtD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—SST—pancreatic cancer	0.001	0.00166	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—DTX1—pancreatic cancer	0.000998	0.00165	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—SSTR3—pancreatic cancer	0.000998	0.00165	CbGpPWpGaD
Fluocinonide—Immune system disorder—Epirubicin—pancreatic cancer	0.000992	0.00251	CcSEcCtD
Fluocinonide—Pain—Docetaxel—pancreatic cancer	0.000989	0.0025	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	0.000981	0.00162	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	0.000979	0.00162	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—PTHLH—pancreatic cancer	0.00097	0.0016	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—PTCH1—pancreatic cancer	0.00097	0.0016	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	0.00096	0.00159	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—SSTR1—pancreatic cancer	0.000957	0.00158	CbGpPWpGaD
Fluocinonide—Erythema—Epirubicin—pancreatic cancer	0.000956	0.00242	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—PPY—pancreatic cancer	0.000938	0.00155	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—SSTR2—pancreatic cancer	0.000921	0.00152	CbGpPWpGaD
Fluocinonide—Immune system disorder—Doxorubicin—pancreatic cancer	0.000918	0.00232	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	0.000914	0.00151	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	0.000907	0.0015	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—NR5A2—pancreatic cancer	0.00089	0.00147	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CCKBR—pancreatic cancer	0.000889	0.00147	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—SST—pancreatic cancer	0.000887	0.00147	CbGpPWpGaD
Fluocinonide—Erythema—Doxorubicin—pancreatic cancer	0.000885	0.00224	CcSEcCtD
Fluocinonide—Hypersensitivity—Docetaxel—pancreatic cancer	0.000852	0.00216	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—DTX4—pancreatic cancer	0.000836	0.00138	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—GLI1—pancreatic cancer	0.000836	0.00138	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	0.000833	0.00138	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CNR1—pancreatic cancer	0.000819	0.00135	CbGpPWpGaD
Fluocinonide—Pruritus—Docetaxel—pancreatic cancer	0.000818	0.00207	CcSEcCtD
Fluocinonide—NR3C1—AP-1 transcription factor network—CDKN2A—pancreatic cancer	0.000817	0.00135	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NRP1—pancreatic cancer	0.000813	0.00135	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000813	0.00135	CbGpPWpGaD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000808	0.00204	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	0.000806	0.00133	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—GCG—pancreatic cancer	0.000791	0.00131	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—HEY2—pancreatic cancer	0.000783	0.0013	CbGpPWpGaD
Fluocinonide—Infection—Epirubicin—pancreatic cancer	0.000775	0.00196	CcSEcCtD
Fluocinonide—NR3C1—Regulation of Androgen receptor activity—SRC—pancreatic cancer	0.000772	0.00128	CbGpPWpGaD
Fluocinonide—Nervous system disorder—Epirubicin—pancreatic cancer	0.000765	0.00194	CcSEcCtD
Fluocinonide—Dizziness—Docetaxel—pancreatic cancer	0.000765	0.00193	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—GAST—pancreatic cancer	0.000765	0.00126	CbGpPWpGaD
Fluocinonide—Skin disorder—Epirubicin—pancreatic cancer	0.000758	0.00192	CcSEcCtD
Fluocinonide—SMO—Signaling by GPCR—AGTR1—pancreatic cancer	0.000754	0.00125	CbGpPWpGaD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000748	0.00189	CcSEcCtD
Fluocinonide—NR3C1—AP-1 transcription factor network—CXCL8—pancreatic cancer	0.000741	0.00123	CbGpPWpGaD
Fluocinonide—Rash—Docetaxel—pancreatic cancer	0.000729	0.00184	CcSEcCtD
Fluocinonide—Dermatitis—Docetaxel—pancreatic cancer	0.000729	0.00184	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—SCT—pancreatic cancer	0.000725	0.0012	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—HEY1—pancreatic cancer	0.000725	0.0012	CbGpPWpGaD
Fluocinonide—Headache—Docetaxel—pancreatic cancer	0.000725	0.00183	CcSEcCtD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—HES1—pancreatic cancer	0.000718	0.00119	CbGpPWpGaD
Fluocinonide—Infection—Doxorubicin—pancreatic cancer	0.000717	0.00181	CcSEcCtD
Fluocinonide—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000708	0.00179	CcSEcCtD
Fluocinonide—Skin disorder—Doxorubicin—pancreatic cancer	0.000701	0.00177	CcSEcCtD
Fluocinonide—NR3C1—Endoderm Differentiation—CTNNB1—pancreatic cancer	0.000699	0.00116	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—HIF1A—pancreatic cancer	0.000696	0.00115	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CCK—pancreatic cancer	0.000692	0.00114	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—CCND1—pancreatic cancer	0.00069	0.00114	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—CTNNB1—pancreatic cancer	0.000683	0.00113	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	0.000681	0.00113	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CNR2—pancreatic cancer	0.000674	0.00111	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—GLP1R—pancreatic cancer	0.000674	0.00111	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—CXCL8—pancreatic cancer	0.000674	0.00111	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—MMP9—pancreatic cancer	0.00067	0.00111	CbGpPWpGaD
Fluocinonide—Pain—Epirubicin—pancreatic cancer	0.000667	0.00169	CcSEcCtD
Fluocinonide—NR3C1—AP-1 transcription factor network—PTEN—pancreatic cancer	0.000666	0.0011	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CCKAR—pancreatic cancer	0.000663	0.0011	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—pancreatic cancer	0.000653	0.00108	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—JAG2—pancreatic cancer	0.000643	0.00106	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—MEN1—pancreatic cancer	0.000634	0.00105	CbGpPWpGaD
Fluocinonide—Pain—Doxorubicin—pancreatic cancer	0.000617	0.00156	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—SHH—pancreatic cancer	0.000605	0.001	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—HIF1A—pancreatic cancer	0.000601	0.000995	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NOTCH4—pancreatic cancer	0.000601	0.000994	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—IAPP—pancreatic cancer	0.000597	0.000987	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—PPARG—pancreatic cancer	0.000592	0.000979	CbGpPWpGaD
Fluocinonide—Hypersensitivity—Epirubicin—pancreatic cancer	0.000575	0.00145	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—PTHLH—pancreatic cancer	0.000573	0.000948	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PTCH1—pancreatic cancer	0.000573	0.000948	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—RB1—pancreatic cancer	0.000566	0.000937	CbGpPWpGaD
Fluocinonide—NR3C1—Endoderm Differentiation—TGFB1—pancreatic cancer	0.000565	0.000935	CbGpPWpGaD
Fluocinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—pancreatic cancer	0.000556	0.00092	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—MYC—pancreatic cancer	0.000553	0.000915	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—TGFB1—pancreatic cancer	0.000552	0.000913	CbGpPWpGaD
Fluocinonide—Pruritus—Epirubicin—pancreatic cancer	0.000552	0.0014	CcSEcCtD
Fluocinonide—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000532	0.00135	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—SST—pancreatic cancer	0.000524	0.000867	CbGpPWpGaD
Fluocinonide—Dizziness—Epirubicin—pancreatic cancer	0.000516	0.0013	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—JAG1—pancreatic cancer	0.000513	0.000848	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—CHD3—pancreatic cancer	0.000512	0.000846	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—MEN1—pancreatic cancer	0.000511	0.000846	CbGpPWpGaD
Fluocinonide—Pruritus—Doxorubicin—pancreatic cancer	0.000511	0.00129	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—NOTCH3—pancreatic cancer	0.000511	0.000845	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—pancreatic cancer	0.000492	0.000815	CbGpPWpGaD
Fluocinonide—Rash—Epirubicin—pancreatic cancer	0.000492	0.00124	CcSEcCtD
Fluocinonide—Dermatitis—Epirubicin—pancreatic cancer	0.000492	0.00124	CcSEcCtD
Fluocinonide—Headache—Epirubicin—pancreatic cancer	0.000489	0.00124	CcSEcCtD
Fluocinonide—NR3C1—Generic Transcription Pathway—NOTCH4—pancreatic cancer	0.000485	0.000802	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CNR1—pancreatic cancer	0.000484	0.0008	CbGpPWpGaD
Fluocinonide—Dizziness—Doxorubicin—pancreatic cancer	0.000477	0.00121	CcSEcCtD
Fluocinonide—SMO—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000469	0.000776	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—GCG—pancreatic cancer	0.000467	0.000773	CbGpPWpGaD
Fluocinonide—Rash—Doxorubicin—pancreatic cancer	0.000455	0.00115	CcSEcCtD
Fluocinonide—Dermatitis—Doxorubicin—pancreatic cancer	0.000455	0.00115	CcSEcCtD
Fluocinonide—NR3C1—AP-1 transcription factor network—TP53—pancreatic cancer	0.000455	0.000752	CbGpPWpGaD
Fluocinonide—Headache—Doxorubicin—pancreatic cancer	0.000452	0.00114	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—AGTR1—pancreatic cancer	0.000446	0.000737	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—STK11—pancreatic cancer	0.000439	0.000727	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—NR5A2—pancreatic cancer	0.000429	0.000709	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—CTNNB1—pancreatic cancer	0.000416	0.000689	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000413	0.000683	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—NOTCH3—pancreatic cancer	0.000412	0.000682	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—pancreatic cancer	0.0004	0.000662	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—CXCL8—pancreatic cancer	0.00039	0.000645	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—SMAD4—pancreatic cancer	0.000385	0.000636	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—HES1—pancreatic cancer	0.000376	0.000621	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—CASP3—pancreatic cancer	0.000373	0.000618	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—STAT3—pancreatic cancer	0.000363	0.0006	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—CTNNB1—pancreatic cancer	0.00036	0.000595	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—PIK3CB—pancreatic cancer	0.00036	0.000595	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CXCL8—pancreatic cancer	0.000346	0.000572	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—pancreatic cancer	0.000342	0.000565	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—pancreatic cancer	0.000338	0.000559	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—TGFB1—pancreatic cancer	0.000336	0.000557	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—TERT—pancreatic cancer	0.000329	0.000544	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—pancreatic cancer	0.000317	0.000524	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—HIF1A—pancreatic cancer	0.000315	0.000521	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—TNF—pancreatic cancer	0.000314	0.00052	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—TSC2—pancreatic cancer	0.000314	0.000519	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—SMAD4—pancreatic cancer	0.000311	0.000514	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—APOE—pancreatic cancer	0.000307	0.000508	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—KDR—pancreatic cancer	0.000301	0.000498	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NFKBIA—pancreatic cancer	0.000286	0.000474	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NOTCH1—pancreatic cancer	0.000284	0.000469	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PIK3CG—pancreatic cancer	0.000277	0.000459	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—NRAS—pancreatic cancer	0.000277	0.000459	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—EGF—pancreatic cancer	0.000274	0.000453	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—TNF—pancreatic cancer	0.000272	0.000449	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—EGFR—pancreatic cancer	0.000253	0.000418	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—MEN1—pancreatic cancer	0.000246	0.000407	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PIK3CD—pancreatic cancer	0.000244	0.000403	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—KRAS—pancreatic cancer	0.000239	0.000395	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—NOTCH4—pancreatic cancer	0.000233	0.000386	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—NOTCH1—pancreatic cancer	0.000229	0.000379	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—HSPA1B—pancreatic cancer	0.000223	0.000368	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—PIK3CA—pancreatic cancer	0.000219	0.000363	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—PPARG—pancreatic cancer	0.000216	0.000357	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PIK3CB—pancreatic cancer	0.000212	0.000351	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CXCL8—pancreatic cancer	0.000204	0.000338	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—HRAS—pancreatic cancer	0.000203	0.000336	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—EZH2—pancreatic cancer	0.000203	0.000335	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—NOTCH3—pancreatic cancer	0.000198	0.000328	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CASP3—pancreatic cancer	0.000195	0.000323	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CCND1—pancreatic cancer	0.00019	0.000315	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CTNNB1—pancreatic cancer	0.000188	0.000312	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—HSPA1A—pancreatic cancer	0.000188	0.000311	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—MMP9—pancreatic cancer	0.000185	0.000305	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PTEN—pancreatic cancer	0.000184	0.000304	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—AKT1—pancreatic cancer	0.000179	0.000296	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—SRC—pancreatic cancer	0.00017	0.000282	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—VEGFA—pancreatic cancer	0.000166	0.000274	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—STAT3—pancreatic cancer	0.000164	0.000272	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NRAS—pancreatic cancer	0.000164	0.000271	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—MYC—pancreatic cancer	0.000153	0.000252	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—TGFB1—pancreatic cancer	0.000152	0.000252	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—SMAD4—pancreatic cancer	0.000149	0.000247	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—EGFR—pancreatic cancer	0.000149	0.000247	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—KRAS—pancreatic cancer	0.000141	0.000233	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PIK3CA—pancreatic cancer	0.00013	0.000214	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—TP53—pancreatic cancer	0.000125	0.000207	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—MYC—pancreatic cancer	0.000123	0.000204	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—HRAS—pancreatic cancer	0.00012	0.000198	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—NOTCH1—pancreatic cancer	0.00011	0.000182	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—AKT1—pancreatic cancer	0.000106	0.000175	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—PPARG—pancreatic cancer	0.000104	0.000172	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—MYC—pancreatic cancer	5.93e-05	9.81e-05	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—AKT1—pancreatic cancer	4.11e-05	6.8e-05	CbGpPWpGaD
